
Basil K. Williams Jr.
Breaking new ground in the field of ophthalmology, Dr. Basil K. Williams Jr. serves as an Adjunct Associate Professor at the University of Cincinnati College of Medicine, where he holds the prestigious Mary Knight Asbury Chair of Ophthalmic Pathology & Ocular Oncology. With a robust academic and clinical background, Dr. Williams has dedicated his career to advancing the understanding and treatment of retinal diseases and ocular oncology. Dr. Williams completed his rigorous training with fellowships in Ocular Oncology and Surgical Retina, following a comprehensive residency in Ophthalmology. His board certification in Ophthalmology underscores his expertise and commitment to the field. His clinical interests are diverse, focusing on conditions such as Age-related Macular Degeneration, Choroidal Hemangioma, and various types of eye cancers, reflecting his deep commitment to improving patient outcomes in these challenging areas. A prolific researcher, Dr. Williams has contributed numerous peer-reviewed articles to the field of ophthalmology, sharing his insights and findings with the global medical community. His research interests are centered around retinal diseases and ocular oncology, where he continually seeks to push the boundaries of current medical knowledge and practice. In addition to his research and clinical work, Dr. Williams is deeply involved in mentoring the next generation of ophthalmologists. His role at the University of Cincinnati allows him to impart his extensive knowledge and experience to students and colleagues, fostering a collaborative and innovative learning environment. Dr. Williams's dedication to his field is evident not only in his academic and clinical pursuits but also in his ongoing commitment to patient care. His work continues to impact the lives of many, as he strives to develop new treatments and improve existing therapies for complex eye conditions. Through his leadership and expertise, Dr. Basil K. Williams Jr. remains a pivotal figure in ophthalmology, continually advancing the field and enhancing the quality of care for patients with retinal and ocular conditions.
Publications
, 191-196, 2022-01-01